期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 11, 期 16, 页码 2029-2038出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156802611796575876
关键词
Apicoplast; chemotherapy; drug targets; Echinococcus; Giardia; mechanism of action; Neospora; Plasmodium; Toxoplasma
资金
- Swiss National Science Foundation [31003A_127374/1, 31003A-125990]
- Swiss Life Foundation
- OPO-Foundation
- Bangerter-Rhyner Foundation
- Helsana Foundation
- Novartis Animal Health
- Swiss National Science Foundation (SNF) [31003A_127374] Funding Source: Swiss National Science Foundation (SNF)
The increasing demand for novel anti-parasitic drugs due to resistance formation to well-established chemotherapeutically important compounds has increased the demands for a better understanding of the mechanism(s) of action of existing drugs and of drugs in development. While different approaches have been developed to identify the targets and thus mode of action of anti-parasitic compounds, it has become clear that many drugs act not only on one, but possibly several parasite molecules or even pathways. Ideally, these targets are not present in any cells of the host. In the case of apicomplexan parasites, the unique apicoplast, provides a suitable target for compounds binding to DNA or ribosomal RNA of prokaryotic origin. In the case of intracellular pathogens, a given drug might not only affect the pathogen by directly acting on parasite-associated targets, but also indirectly, by altering the host cell physiology. This in turn could affect the parasite development and lead to parasite death. In this review, we provide an overview of strategies for target identification, and present examples of selected drug targets, ranging from proteins to nucleic acids to intermediary metabolism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据